...
首页> 外文期刊>Pilot and Feasibility Studies >Developing an intervention to optimise the outcome of cardiac surgery in people with diabetes: the OCTOPuS pilot study
【24h】

Developing an intervention to optimise the outcome of cardiac surgery in people with diabetes: the OCTOPuS pilot study

机译:制定干预以优化糖尿病人类心脏手术的结果:章鱼试点研究

获取原文

摘要

BackgroundCardiothoracic surgical outcomes are poorer in people with diabetes compared with those without diabetes. There are two important uncertainties in the management of people with diabetes undergoing major surgery: (1) how to improve diabetes management in the weeks leading up to an elective procedure and (2) whether that improved management leads to improved postoperative outcomes. The aim of this study was to develop and pilot a specialist diabetes team-led intervention to improve surgical outcomes in people with diabetes.DesignOpen pilot feasibility studySettingDiabetes and cardiothoracic surgery departments, University Hospital Southampton NHS Foundation TrustParticipantsSeventeen people with diabetes undergoing cardiothoracic surgeryInterventionFollowing two rapid literature reviews, a prototype intervention was developed based on a previously used nurse-led outpatient intervention and tested.Primary outcomeFeasibility and acceptability of delivering the interventionSecondary outcomesBiomedical data were collected at baseline and prior to surgery. We assessed how the intervention was used. In depth qualitative interviews with participants and healthcare professionals were used to explore perceptions and experiences of the intervention and how it might be improved.ResultsThirteen of the 17 people recruited completed the study and underwent cardiothoracic surgery. All components of the OCTOPuS intervention were used, but not all parts were used for all participants. Minor changes were made to the intervention as a result of feedback from the participants and healthcare professionals. Median (IQR) HbA_(1c) was 10 mmol/mol (3, 13) lower prior to surgery than at baseline.ConclusionThis study has shown that it is possible to develop a clinical pathway to improve diabetes management prior to admission. The clinical and cost-effectiveness of this intervention will now be tested in a multicentre randomised controlled trial in cardiothoracic centres across the UK.Trial registrationISRCTN; ISRCTN10170306. Registered 10 May 2018.
机译:背景Cardiothoracic的外科手术结果与糖尿病的人较差,与没有糖尿病的人相比。在经过主要手术的糖尿病患者中有两种重要的不确定性:(1)如何改善患有选修程序的几周内的糖尿病管理和(2)改进的管理层是否导致术后改善的术后结果。本研究的目的是开发和试点专科糖尿病团队导向干预,以改善糖尿病人类的手术结果。Designopen先导可行性StudysettingDiabetes和Cardihothoracic手术部门,大学医院南安普敦NHS基金会TrustPartpartparteventsSeventeen venteen venteen venteen venteen人与糖尿病患有糖尿病患者进行的糖尿病患者进行了两种快速文学评论,基于先前使用的护士LED门诊干预和测试开发了一种原型干预。在基线和手术前收集了递送干预膜等再生成分生物数据的预先开展的预先结果和可接受性。我们评估了如何使用干预。在深入的与参与者和医疗保健专业人员采访中,用于探索干预的感知和经验以及如何改进。17人招募的17人招募了这项研究并接受了心胸外科。使用章鱼干预的所有组分,但并非所有部分都用于所有参与者。由于参与者和医疗保健专业人员的反馈而对干预进行了微小的变化。在手术前的中位数(IQR)HBA_(1C)比在术前,比在基线到基线。结论,研究表明,在入院前,可以开发一种临床途径以改善糖尿病管理。这种干预的临床和成本效益现在将在英国的Cardihothoracic Centers中的多期式随机对照试验中进行测试ISRCTN10170306。 2018年5月10日注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号